Skip to main content
CDC Website

HIV and AIDS

Opportunities for HIV Cure Strategies at the Time of ART Initiation (R21 Clinical Trial Not Allowed)

The purpose of this Notice of Funding Opportunity (NOFO) is to identify cure strategies suitable for administration at the start of combination antiretroviral therapy (cART) and/or at cART restart after an analytical treatment interruption (ATI), with the ultimate goal of achieving sustained treatment-free remission.

Opportunities for HIV Cure Strategies at the Time of ART Initiation (R01 Clinical Trial Not Allowed

The purpose of this Notice of Funding Opportunity (NOFO) is to identify cure strategies suitable for administration at the start of combination antiretroviral therapy (cART) and/or at cART restart after an analytical treatment interruption (ATI), with the ultimate goal of achieving sustained treatment-free remission.

Best Practices for Community Engagement from a Public Health Perspective

RAISE and NASTAD’s webinar, “Best Practices for Community Engagement from a Public Health Perspective,” took place on Wednesday, July 19. This webinar featured two speakers discussing community engagement best practices, from a public health perspective. The discussion focused on approaches to assessing community preferences for public health interventions. 

Integrating Implementation Science Methods into Health Department HIV Programs and Evaluation

RAISE and NASTAD’s webinar, “Integrating Implementation Science Methods into Health Department HIV Programs & Evaluation,” took place on Wednesday, June 21, 2023. This webinar featured the New York City Department of Health and Mental Hygiene and the Philadelphia Department of Public Health’s efforts to incorporate implementation science methods into HIV programming and evaluation.

Low-Barrier Care as Part of Differentiated Service Delivery for People with HIV

The webinar, “Low-Barrier Care as Part of Differentiated Service Delivery for People with HIV”, was held on Wednesday, May 17, 2023. Dr. Julie Dombrowski, Associate Professor of Medicine at the University of Washington and Deputy Director of the Public Health for Seattle & King County’s (PHSKC) HIV/STD Program, gave this talk. The webinar explored low-barrier HIV care, its purpose and design, and discuss how PHSKC has implemented this model. This webinar was co-sponsored by RAISE and NASTAD. 

Planning for Product Development Strategy (R34 Clinical Trial Not Allowed)

The purpose of this Notice of Funding Opportunity (NOFO) is to support the development of a comprehensive and well-defined product development strategy for next-generation treatments for HIV and HIV-associated comorbidities, coinfections and complication and preventive strategies for HIV, as well as facilitating the translation of research findings into drug products that enables submission of an Investigational New Drug (IND) application to the FDA.

HIV Data Privacy, Criminalization, and the Role of Health Departments

On June 23, 2023, NASTAD held a webinar, “HIV Data Privacy, Criminalization, and the Role of Health Departments.” This webinar provided an overview of NASTAD’s newly updated resource “U.S. HIV Data Protection Landscape,” including trends and findings from a comprehensive 53-jurisdiction review of HIV data privacy laws and regulations, followed by a discussion with two guest speakers about the role of health departments and legal counsel in upholding and strengthening HIV data protections. 

Stimulant Safety Getting Amped Up to Reduce Harms When Using Stimulants

This resource provides an overview of stimulants and aims to educate individuals and organizations that provide services to people who use methamphetamine and other stimulants. This resource offers education on the reasons people take stimulants, including the potential positive aspects to use and potential risks of use; how to minimize harm, reduce stigma around stimulants, and support peoples’ positive experiences. It discusses the intersection of stimulant use and sexual safety; tips

The Path That Ends AIDS

This report makes clear that there is a path to end AIDS. Taking that path will help ensure preparedness to address other pandemic challenges, and advance progress across the Sustainable Development Goals. The data and real-world examples in the report make it very clear what that path is. It is not a mystery. It is a choice. Some leaders are already following the path—and succeeding.